Screener
Intellia Therapeutics NTLA Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Intellia Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337952
FAQ
- What is Intellia Therapeutics's shares (diluted)?
- Intellia Therapeutics (NTLA) reported shares (diluted) of 133.5M in Q2 2026.
- How has Intellia Therapeutics's shares (diluted) changed year-over-year?
- Intellia Therapeutics's shares (diluted) increased by 28.7% year-over-year, from 103.7M to 133.5M.
- What is the long-term trend for Intellia Therapeutics's shares (diluted)?
- Over 4 years (2021 to 2025), Intellia Therapeutics's shares (diluted) has grown at a 11.1% compound annual growth rate (CAGR), from 279.9M to 425.8M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Intellia Therapeutics's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude